BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang Z, Chen JQ, Liu JL, Qin XG, Huang Y. FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: A meta-analysis. World J Gastroenterol 2013; 19(29): 4808-4817 [PMID: 23922481 DOI: 10.3748/wjg.v19.i29.4808]
URL: https://www.wjgnet.com/1007-9327/full/v19/i29/4808.htm
Number Citing Articles
1
Da-Wei Sun, Lin An, Feng Wei, Lin Mu, Xiao-Ju Shi, Chuan-Lei Wang, Zheng-Wei Zhao, Teng-Fei Li, Guo-Yue Lv. Prognostic significance of parameters from pretreatment 18F-FDG PET in hepatocellular carcinoma: a meta-analysisAbdominal Radiology 2016; 41(1): 33 doi: 10.1007/s00261-015-0603-9
2
Victor Hugo Fonseca de Jesus, Wilson Luiz da Costa Junior, Tomás Mansur Duarte de Miranda Marques, Alessandro Landskron Diniz, Héber Salvador de Castro Ribeiro, André Luis de Godoy, Igor Correia de Farias, Felipe José Fernandez Coimbra. Role of staging laparoscopy in the management of Pancreatic Duct Carcinoma (PDAC): Single-center experience from a tertiary hospital in BrazilJournal of Surgical Oncology 2018; 117(5): 819 doi: 10.1002/jso.25024
3
Yoshiyasu Kato, Suguru Yamada, Mitsuru Tashiro, Fuminori Sonohara, Hideki Takami, Masamichi Hayashi, Mitsuro Kanda, Daisuke Kobayashi, Chie Tanaka, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancerHPB 2019; 21(9): 1211 doi: 10.1016/j.hpb.2019.01.012
4
Andrea Gallamini, Colette Zwarthoed, Anna Borra. Positron Emission Tomography (PET) in OncologyCancers 2014; 6(4): 1821 doi: 10.3390/cancers6041821
5
Huajian Gu, Xiaoyan Xin, Yaozhen Pan, Hong Zhang, She Tian, Chengyi Sun. Telomerase Activity as a Marker for Differential Diagnosis of Pancreatic Adenocarcinoma: A Systematic Review and Meta-AnalysisThe International Journal of Biological Markers 2016; 31(2): 126 doi: 10.5301/jbm.5000172
6
Aliya Qayyum, Eric P. Tamm, Ihab R. Kamel, Peter J. Allen, Hina Arif-Tiwari, Victoria Chernyak, Tamas A. Gonda, Joseph R. Grajo, Nicole M. Hindman, Jeanne M. Horowitz, Harmeet Kaur, Michelle M. McNamara, Richard B. Noto, Pavan K. Srivastava, Tasneem Lalani. ACR Appropriateness Criteria® Staging of Pancreatic Ductal AdenocarcinomaJournal of the American College of Radiology 2017; 14(11): S560 doi: 10.1016/j.jacr.2017.08.050
7
Tong Dai, Elizabeta Popa, Manish A. Shah. The Role of 18F-FDG PET Imaging in Upper Gastrointestinal MalignanciesCurrent Treatment Options in Oncology 2014; 15(3): 351 doi: 10.1007/s11864-014-0301-9
8
L. Wang, P. Dong, W.G. Wang, B.L. Tian. Positron emission tomography modalities prevent futile radical resection of pancreatic cancer: A meta-analysisInternational Journal of Surgery 2017; 46: 119 doi: 10.1016/j.ijsu.2017.09.003
9
M. Wartski. Bilan initial d’imagerie de l’adénocarcinome pancréatique : données de la littérature sur la place actuelle de la tomographie par émission de positons au 18F-fluorodéoxyglucose (TEP FDG)Médecine Nucléaire 2019; 43(3): 270 doi: 10.1016/j.mednuc.2018.12.018
10
Elena Incerti, Emilia G. Vanoli, Sara Broggi, Calogero Gumina, Paolo Passoni, Najla Slim, Claudio Fiorino, Michele Reni, Paola Mapelli, Mauro Cattaneo, Silvia Zanon, Riccardo Calandrino, Luigi Gianolli, Nadia Di Muzio, Maria Picchio. Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patientsNuclear Medicine Communications 2019; 40(10): 1072 doi: 10.1097/MNM.0000000000001065
11
Aline Barhli, Jérôme Cros, Laurent Bartholin, Cindy Neuzillet. Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and futureDigestive and Liver Disease 2018; 50(10): 979 doi: 10.1016/j.dld.2018.08.009
12
Masatoyo Nakajo, Yoriko Kajiya, Atsushi Tani, Megumi Jinguji, Masayuki Nakajo, Tohru Nihara, Yoshihiko Fukukura, Takashi Yoshiura. A pilot study of the diagnostic and prognostic values of FLT-PET/CT for pancreatic cancer: comparison with FDG-PET/CTAbdominal Radiology 2017; 42(4): 1210 doi: 10.1007/s00261-016-0987-1
13
Yoshitaka Toyama, Masatoshi Hotta, Fuyuhiko Motoi, Kentaro Takanami, Ryogo Minamimoto, Kei Takase. Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancerScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-73237-3
14
Lulu Zhang, Santosh Sanagapalli, Alina Stoita. Challenges in diagnosis of pancreatic cancerWorld Journal of Gastroenterology 2018; 24(19): 2047-2060 doi: 10.3748/wjg.v24.i19.2047
15
Javier Casillas, Aldo Serafini, Patricia Castillo, Alexander Quiroz, Afonso Ribeiro. Multidisciplinary Teaching Atlas of the Pancreas2016; : 91 doi: 10.1007/978-3-662-46745-9_5
16
David R. Fogelman, Gauri Varadhachary. Medical oncology and pancreatic cancer: what the radiologist needs to knowAbdominal Radiology 2018; 43(2): 383 doi: 10.1007/s00261-017-1432-9
17
Wolfgang Mohnike, Gustav Hör, Andreas Hertel. PET/CT-Atlas2016; : 507 doi: 10.1007/978-3-662-48842-3_15
18
Cindy Neuzillet, Annemilaï Tijeras-Raballand, Philippe Bourget, Jérôme Cros, Anne Couvelard, Alain Sauvanet, Marie-Pierre Vullierme, Christophe Tournigand, Pascal Hammel. State of the art and future directions of pancreatic ductal adenocarcinoma therapyPharmacology & Therapeutics 2015; 155: 80 doi: 10.1016/j.pharmthera.2015.08.006
19
Randy Yeh, Jonathan Steinman, Lyndon Luk, Michael D. Kluger, Elizabeth M. Hecht. Imaging of pancreatic cancer: what the surgeon wants to knowClinical Imaging 2017; 42: 203 doi: 10.1016/j.clinimag.2016.10.002
20
Xi Hu, Fan Xia, Jiyoung Lee, Fangyuan Li, Xiaoyang Lu, Xiaozhen Zhuo, Guangjun Nie, Daishun Ling. Tailor‐Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal AdenocarcinomaAdvanced Science 2021; 8(7): 2002545 doi: 10.1002/advs.202002545
21
Yong-il Kim, Yong Joong Kim, Jin Chul Paeng, Gi Jeong Cheon, Dong Soo Lee, June-Key Chung, Keon Wook Kang. Heterogeneity index evaluated by slope of linear regression on 18F-FDG PET/CT as a prognostic marker for predicting tumor recurrence in pancreatic ductal adenocarcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging 2017; 44(12): 1995 doi: 10.1007/s00259-017-3755-8
22
Norbert Hüser, Volker Aßfalg, Isabel Rauscher, Helmut Friess. The Pancreas2018; : 755 doi: 10.1002/9781119188421.ch99
23
Jeho Jeong, Joseph O. Deasy. Modeling the Relationship between Fluorodeoxyglucose Uptake and Tumor Radioresistance as a Function of the Tumor MicroenvironmentComputational and Mathematical Methods in Medicine 2014; 2014: 1 doi: 10.1155/2014/847162
24
Chen Liang, Yi Qin, Bo Zhang, Shunrong Ji, Si Shi, Wenyan Xu, Jiang Liu, Jinfeng Xiang, Dingkong Liang, Qiangsheng Hu, Liang Liu, Chen Liu, Guopei Luo, Quanxing Ni, Jin Xu, Xianjun Yu. Energy sources identify metabolic phenotypes in pancreatic cancerActa Biochimica et Biophysica Sinica 2016; 48(11): 969 doi: 10.1093/abbs/gmw097
25
Seong Hun Kim, Seung Ok Lee. Developing Consilience Medicine: Positron Emission Tomography Scan and Transcriptomics in Pancreatic CancerGut and Liver 2019; 13(3): 225 doi: 10.5009/gnl19116
26
Mireia Crispin-Ortuzar, Jeho Jeong, Andrew N Fontanella, Joseph O Deasy. A radiobiological model of radiotherapy response and its correlation with prognostic imaging variablesPhysics in Medicine and Biology 2017; 62(7): 2658 doi: 10.1088/1361-6560/aa5d42
27
Katharina Seidensaal, Semi Ben Harrabi, Jürgen Debus. Molecular Imaging in OncologyRecent Results in Cancer Research 2020; 216: 865 doi: 10.1007/978-3-030-42618-7_28
28
Stephanie R. Rice, Michael Chuong, Antony Koroulakis, Osman M. Siddiqui, Ankur M. Sharma, Charles B. Simone, Jason K. Molitoris, Adeel Kaiser. The Utility of PET/Computed Tomography for Radiation Oncology Planning, Surveillance, and Prognosis Prediction of Gastrointestinal TumorsPET Clinics 2020; 15(1): 77 doi: 10.1016/j.cpet.2019.08.004
29
Randy Yeh, Laurent Dercle, Ishan Garg, Zhen Jane Wang, David M. Hough, Ajit H. Goenka. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal AdenocarcinomaAbdominal Radiology 2018; 43(2): 415 doi: 10.1007/s00261-017-1374-2
30
M. Wartski, A. Sauvanet. 18F-FDG PET/CT in pancreatic adenocarcinoma: A role at initial imaging staging?Diagnostic and Interventional Imaging 2019; 100(12): 735 doi: 10.1016/j.diii.2019.07.006
31
Huojun Zhang, Xiaofei Zhu, Zhaochong Zeng, Xianshu Gao. Integrative Pancreatic Intervention Therapy2021; : 523 doi: 10.1016/B978-0-12-819402-7.00023-1
32
TaeWoo Kwon, HyeSook Youn, Beomseok Son, Daehoon Kim, Ki Moon Seong, Sungkyun Park, Wanyeon Kim, BuHyun Youn. DANGER is involved in high glucose-induced radioresistance through inhibiting DAPK-mediated anoikis in non-small cell lung cancerOncotarget 2016; 7(6): 7193 doi: 10.18632/oncotarget.6887
33
M. Wartski, R. Coriat, P.Y. Salaün. Cancers du pancréasMédecine Nucléaire 2019; 43(1): 61 doi: 10.1016/j.mednuc.2018.12.008
34
Seung Hyup Hyun, Ho Seong Kim, Seong Ho Choi, Dong Wook Choi, Jong Kyun Lee, Kwang Hyuck Lee, Joon Oh Park, Kyung-Han Lee, Byung-Tae Kim, Joon Young Choi. Intratumoral heterogeneity of 18F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging 2016; 43(8): 1461 doi: 10.1007/s00259-016-3316-6
35
Terumi Kamisawa, Laura D Wood, Takao Itoi, Kyoichi Takaori. Pancreatic cancerThe Lancet 2016; 388(10039): 73 doi: 10.1016/S0140-6736(16)00141-0
36
Jarrod D. Predina, Andrew D. Newton, Jane Keating, Eduardo M. Barbosa, Olugbenga Okusanya, Leilei Xia, Ashley Dunbar, Courtney Connolly, Michael P. Baldassari, Jack Mizelle, Edward J. Delikatny, John C. Kucharczuk, Charuhas Deshpande, Sumith A. Kularatne, Phillip Low, Jeffrey Drebin, Sunil Singhal. Intraoperative Molecular Imaging Combined With Positron Emission Tomography Improves Surgical Management of Peripheral Malignant Pulmonary NodulesAnnals of Surgery 2017; 266(3): 479 doi: 10.1097/SLA.0000000000002382
37
Kumi Ozaki, Kenichi Harada, Noboru Terayama, Nobuyuki Kosaka, Hirohiko Kimura, Toshifumi Gabata. FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular backgroundJapanese Journal of Radiology 2020; 38(8): 697 doi: 10.1007/s11604-020-00961-1
38
Brandon A. Howard, Terence Z. Wong. 18F-FDG-PET/CT Imaging for Gastrointestinal MalignanciesRadiologic Clinics of North America 2021; 59(5): 737 doi: 10.1016/j.rcl.2021.06.001
39
Haiqun Xing, Zhixin Hao, Wenjia Zhu, Dehui Sun, Jie Ding, Hui Zhang, Yu Liu, Li Huo. Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomicsEJNMMI Research 2021; 11(1) doi: 10.1186/s13550-021-00760-3
40
Seoung Yoon Rho, Mijin Yun, Chang Moo Kang, Sung Hwan Lee, Ho Kyoung Hwang, Woo Jung Lee. Different biological behaviors in left-sided pancreatic cancer according to Yonsei criteria: Proposal of a modified Yonsei criteria scorePancreatology 2018; 18(8): 990 doi: 10.1016/j.pan.2018.09.001
41
Friedrich Anger, Anna Döring, Jacob van Dam, Johan Friso Lock, Ingo Klein, Max Bittrich, Christoph-Thomas Germer, Armin Wiegering, Volker Kunzmann, Casper van Eijck, Stefan Löb. Impact of Borderline Resectability in Pancreatic Head Cancer on Patient Survival: Biology Matters According to the New International Consensus CriteriaAnnals of Surgical Oncology 2021; 28(4): 2325 doi: 10.1245/s10434-020-09100-6
42
Pratyusha Nunna, Sara Sheikhbahaei, Sejin Ahn, Brenda Young, Rathan M. Subramaniam. The Role of Positron Emission Tomography/Computed Tomography in Management and Prediction of Survival in Pancreatic CancerJournal of Computer Assisted Tomography 2016; 40(1): 142 doi: 10.1097/RCT.0000000000000323
43
Maxime Ronot, Ashley Kieran Clift, Valérie Vilgrain, Andrea Frilling. Functional imaging in liver tumoursJournal of Hepatology 2016; 65(5): 1017 doi: 10.1016/j.jhep.2016.06.024
44
Dongyong Zhu, Lisha Wang, Hanfei Zhang, Jie Chen, Yanfang Wang, Sama Byanju, Meiyan Liao. Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinomaMedicine 2017; 96(33): e7813 doi: 10.1097/MD.0000000000007813
45
Monica Greco, Simone Negrini, Chiara Schiavi, Francesca Giusti, Matteo Borro, Chiara Vassallo, Francesco Puppo, Giuseppe Murdaca. An Uncommon Presentation of Pancreatic CarcinomaThe American Journal of Medicine 2019; 132(6): e583 doi: 10.1016/j.amjmed.2019.02.020
46
Naveen M. Kulkarni, Erik V. Soloff, Parag P. Tolat, Guillermo P. Sangster, Jason B. Fleming, Olga R. Brook, Zhen Jane Wang, Elizabeth M. Hecht, Marc Zins, Priya R. Bhosale, Hina Arif-Tiwari, Lorenzo Mannelli, Avinash R. Kambadakone, Eric P. Tamm. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology’s disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable diseaseAbdominal Radiology 2020; 45(3): 716 doi: 10.1007/s00261-019-02289-5
47
Li Wang, Ping Dong, Guohua Shen, Shengzhong Hou, Yi Zhang, Xubao Liu, Bole Tian. 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Treatment Efficacy and Clinical Outcome for Patients With Pancreatic CarcinomaPancreas 2019; 48(8): 996 doi: 10.1097/MPA.0000000000001375
48
V. M. Petriev, V. K. Tishchenko, R. N. Krasikova. 18F-FDG and Other Labeled Glucose Derivatives for Use in Radionuclide Diagnosis of Oncological Diseases (Review)Pharmaceutical Chemistry Journal 2016; 50(4): 209 doi: 10.1007/s11094-016-1425-y
49
Fathinul Fikri Ahmad Saad, Anna Misyail Abdul Rashid, Mohamad Syafeeq Faeez Md Noh. Incremental Role of Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Assessment of Computed Tomography-Inconspicuous Pancreatic LesionsJournal of Pancreatic Cancer 2017; 3(1): 66 doi: 10.1089/pancan.2017.0014
50
Katherine M. Bever, Erkut H. Borazanci, Elizabeth A. Thompson, Jennifer N. Durham, Kimberly Pinero, Gayle S. Jameson, Amber Vrana, Meizheng Liu, Cara Wilt, Annie A. Wu, Wei Fu, Hao Wang, Yafu Yin, Jeffrey P. Leal, Ana De Jesus-Acosta, Lei Zheng, Daniel A. Laheru, Daniel D. Von Hoff, Elizabeth M. Jaffee, Jonathan D. Powell, Dung T. Le. An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinomaOncotarget 2020; 11(21): 1929 doi: 10.18632/oncotarget.27586
51
Andreas Odparlik. Kompendium Internistische OnkologieSpringer Reference Medizin 2020; : 1 doi: 10.1007/978-3-662-46764-0_158-1
52
Ricardo P. Martinho, Qingjia Bao, Stefan Markovic, Dina Preise, Keren Sasson, Lilach Agemy, Avigdor Scherz, Lucio Frydman. Identification of variable stages in murine pancreatic tumors by a multiparametric approach employing hyperpolarized 13 C MRSI, 1 H diffusivity and 1 H T 1 MRI NMR in Biomedicine 2021; 34(2) doi: 10.1002/nbm.4446
53
Sara Sheikhbahaei, Rick Wray, Brenda Young, Esther Mena, Mehdi Taghipour, Arman Rahmim, Rathan M. Subramaniam. 18F-FDG-PET/CT therapy assessment of locally advanced pancreatic adenocarcinomaNuclear Medicine Communications 2016; 37(3): 231 doi: 10.1097/MNM.0000000000000436
54
Claudio Scafoglio, Bruce A. Hirayama, Vladimir Kepe, Jie Liu, Chiara Ghezzi, Nagichettiar Satyamurthy, Neda A. Moatamed, Jiaoti Huang, Hermann Koepsell, Jorge R. Barrio, Ernest M. Wright. Functional expression of sodium-glucose transporters in cancerProceedings of the National Academy of Sciences 2015; 112(30): E4111 doi: 10.1073/pnas.1511698112
55
Nicola Silvestris, Vito Longo, Francesco Cellini, Michele Reni, Alessandro Bittoni, Ivana Cataldo, Stefano Partelli, Massimo Falconi, Aldo Scarpa, Oronzo Brunetti, Vito Lorusso, Daniele Santini, Alessio Morganti, Vincenzo Valentini, Stefano Cascinu. Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinomaCritical Reviews in Oncology/Hematology 2016; 98: 309 doi: 10.1016/j.critrevonc.2015.11.016
56
Cindy Neuzillet, Sébastien Gaujoux, Nicolas Williet, Jean-Baptiste Bachet, Lucile Bauguion, Laurianne Colson Durand, Thierry Conroy, Laetitia Dahan, Marine Gilabert, Florence Huguet, Lysiane Marthey, Julie Meilleroux, Louis de Mestier, Bertrand Napoléon, Fabienne Portales, Antonio Sa Cunha, Lilian Schwarz, Julien Taieb, Benoist Chibaudel, Olivier Bouché, Pascal Hammel. Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)Digestive and Liver Disease 2018; 50(12): 1257 doi: 10.1016/j.dld.2018.08.008
57
Salvatore Annunziata, Daniele Antonio Pizzuto, Federica Galiandro. Evidence-based Positron Emission Tomography2020; : 59 doi: 10.1007/978-3-030-47701-1_7
58
Masato Ogura, Naoto Shikano, Syuichi Nakajima, Junichi Sagara, Naoto Yamaguchi, Kentaro Kusanagi, Yuya Okui, Asuka Mizutani, Masato Kobayashi, Keiichi Kawai. A strategy for improving FDG accumulation for early detection of metastasis from primary pancreatic cancer: Stimulation of the Warburg effect in AsPC-1 cellsNuclear Medicine and Biology 2015; 42(5): 475 doi: 10.1016/j.nucmedbio.2014.12.017
59
P. E. Tulin, M. B. Dolgushin, D. I. Nevzorov, P. V. Kochergin, Yu. I. Patyutko. PET/CT IN THE DIAGNOSIS OF PANCREATIC CANCER: LITERATURE REVIEWMedical Visualization 2018; (1): 57 doi: 10.24835/1607-0763-2018-1-57-67
60
Hong-tao Wei, Guang-yong Chen, Peng Li. Mediastinum metastasis in a post-surgical pancreatic cancer patient successfully confirmed with endoscopic ultrasonographyWorld Journal of Emergency Medicine 2021; 12(3): 244 doi: 10.5847/wjem.j.1920-8642.2021.03.017
61
G. Layer, E.S. Fuchs, J. Hoffend. Moderne Pankreasdiagnostik bei TumorverdachtDer Gastroenterologe 2014; 9(1): 21 doi: 10.1007/s11377-013-0820-0
62
Jin He, David Cosgrove, Joseph M. Herman, Timothy M. Pawlik. Noncolorectal, Nonneuroendocrine Liver Metastases2015; : 95 doi: 10.1007/978-3-319-09293-5_8
63
Hyung Rae Kim, Minjung Seo, Yang Won Nah, Hyung Woo Park, Seol Hoon Park. Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancerNuclear Medicine Communications 2018; 39(7): 691 doi: 10.1097/MNM.0000000000000855
64
Fanxiao Liu, Qingyu Zhang, Dezhi Zhu, Fengxia Liu, Zhenfeng Li, Jianmin Li, Bomin Wang, Dongsheng Zhou, Jinlei Dong. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone SarcomaMedicine 2015; 94(36): e1462 doi: 10.1097/MD.0000000000001462
65
Tamara M H Gall, Harpreet Wasan, Long R Jiao. Pancreatic cancer: current understanding of molecular and genetic aetiologiesPostgraduate Medical Journal 2015; 91(1080): 594 doi: 10.1136/postgradmedj-2014-133161
66
Lei Jiang, Qiying Tang, Cedric Panje, Hongting Nie, Guochao Zhao, Hongcheng Shi. Assessment of pancreatic colloid carcinoma using 18F‑FDG PET/CT compared with MRI and enhanced CTOncology Letters 2018;  doi: 10.3892/ol.2018.8859
67
Asha Kandathil, Rathan M. Subramaniam. Imaging Diagnostics in Pancreatic CancerClinical Gastroenterology 2021; : 89 doi: 10.1007/978-3-030-69940-6_5
68
Jin-Ping Lai, Yong Yue, Wei Zhang, Yihua Zhou, David Frishberg, Laith H. Jamil, James M. Mirocha, Maha Guindi, Bonnie Balzer, Shikha Bose, Dengfeng Cao, Simon Lo, Xuemo Fan, Joanne K. Rutgers. Comparison of endoscopic ultrasound guided fine needle aspiration and PET/CT in preoperative diagnosis of pancreatic adenocarcinomaPancreatology 2017; 17(4): 617 doi: 10.1016/j.pan.2017.04.008
69
Wataru Izumo, Ryota Higuchi, Toru Furukawa, Takehisa Yazawa, Shuichiro Uemura, Masahiro Shiihara, Masakazu Yamamoto. Evaluation of preoperative prognostic factors in patients with resectable invasive intraductal papillary mucinous carcinomaSurgery 2020; 168(6): 994 doi: 10.1016/j.surg.2020.01.014
70
Paula Ghaneh, Robert Hanson, Andrew Titman, Gill Lancaster, Catrin Plumpton, Huw Lloyd-Williams, Seow Tien Yeo, Rhiannon Tudor Edwards, Colin Johnson, Mohammed Abu Hilal, Antony P Higginson, Tom Armstrong, Andrew Smith, Andrew Scarsbrook, Colin McKay, Ross Carter, Robert P Sutcliffe, Simon Bramhall, Hemant M Kocher, David Cunningham, Stephen P Pereira, Brian Davidson, David Chang, Saboor Khan, Ian Zealley, Debashis Sarker, Bilal Al Sarireh, Richard Charnley, Dileep Lobo, Marianne Nicolson, Christopher Halloran, Michael Raraty, Robert Sutton, Sobhan Vinjamuri, Jonathan Evans, Fiona Campbell, Jon Deeks, Bal Sanghera, Wai-Lup Wong, John P Neoptolemos. PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancerHealth Technology Assessment 2018; 22(7): 1 doi: 10.3310/hta22070
71
Young-Jae Hwang, Seon Mee Park, Soomin Ahn, Jong-Chan Lee, Young Soo Park, Nayoung Kim. Accuracy of an administrative database for pancreatic cancer by international classification of disease 10<sup>th</sup> codes: A retrospective large-cohort studyWorld Journal of Gastroenterology 2019; 25(37): 5619-5629 doi: 10.3748/wjg.v25.i37.5619
72
Xinjin Gu, Ruiquan Zhou, Chenggang Li, Rong Liu, Zhiming Zhao, Yuanxing Gao, Yong Xu. Preoperative maximum standardized uptake value and carbohydrate antigen 19–9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinomaBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5691-4
73
Venkata Subramanian Krishnaraju, Rajender Kumar, Bhagwant Rai Mittal, Vishal Sharma, Harjeet Singh, Ritambhra Nada, Amanjit Bal, Manish Rohilla, Harmandeep Singh, Surinder S. Rana. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenueEuropean Radiology 2021; 31(4): 2199 doi: 10.1007/s00330-020-07318-2
74
Krzysztof Kilian, Bartłomiej Chabecki, Justyna Kiec, Agnieszka Kunka, Barbara Panas, Maciej Wójcik, Anna Pękal. Synthesis, quality control and determination of metallic impurities in 18F-fludeoxyglucose production processReports of Practical Oncology & Radiotherapy 2014; 19: S22 doi: 10.1016/j.rpor.2014.03.001
75
Wataru Izumo, Ryota Higuchi, Toru Furukawa, Takehisa Yazawa, Shuichirou Uemura, Masahiro Shiihara, Masakazu Yamamoto. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinomaScandinavian Journal of Gastroenterology 2019; 54(6): 780 doi: 10.1080/00365521.2019.1624816
76
Jeong Won Lee, Joo Hyun O, Miyoung Choi, Joon Young Choi. Impact of F-18 Fluorodeoxyglucose PET/CT and PET/MRI on Initial Staging and Changes in Management of Pancreatic Ductal Adenocarcinoma: A Systemic Review and Meta-AnalysisDiagnostics 2020; 10(11): 952 doi: 10.3390/diagnostics10110952
77
Juliano J. Cerci, Mateos Bogoni, Dominique Delbeke. Oncological PET/CT with Histological Confirmation2016; : 77 doi: 10.1007/978-3-319-27880-3_7